Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1,8 Naphthalic Anhydride Derivatives. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110804039B reveals novel phthalimide-containing 1,8-naphthalic anhydride synthesis. Enhances antitumor selectivity and offers scalable pharmaceutical intermediate manufacturing solutions.